Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen (Q84539941)
scientific article published on 11 July 2011
Language:
(P31) (Q13442814)
(P50) (Q59161104)
(Q57065724)
(P304) 785-790
(P407) (Q1860)
(P433) 3
(P478) 23
(P577) Monday, July 11, 2011
(P921) (Q413299)
(Q420436)
(P1433) (Q326122)
(P1476) "Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen" (language: en)
(P2093) S-J Lee
S Movva
L A Cerilli
S Eberhardt
B Schmit
R Quinn
C Y Muller
I Rabinowitz
M Purdy
D Snyder
T Bocklage
other details
description scientific article published on 11 July 2011

External Links